Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
Cirrhosis & Complications
4
Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
Cirrhosis & Complications
4
Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
Cirrhosis & Complications
4
Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
General Hepatology
5
Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023
View
General Hepatology
5
Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023
View
General Hepatology
5
Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023
View
General Hepatology
5
Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023
View
General Hepatology
5
Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023
View
Metabolism, Alcohol & Toxicity
6
Medscape Education Global – supported by an Independent educational grant from Madrigal Pharmaceuticals: "Emerging Treatment strategies for NASH: On the road to resolution?" - EASL Congress 2023
View
Metabolism, Alcohol & Toxicity
6
Medscape Education Global – supported by an Independent educational grant from Madrigal Pharmaceuticals: "Emerging Treatment strategies for NASH: On the road to resolution?" - EASL Congress 2023
View
Metabolism, Alcohol & Toxicity
6
Medscape Education Global – supported by an Independent educational grant from Madrigal Pharmaceuticals: "Emerging Treatment strategies for NASH: On the road to resolution?" - EASL Congress 2023
